1. Immune-mediated hemolysis after administration of human intravenous immunoglobulin in a dog: a case report.
- Author
-
Minji Kim, Youngju Kim, Hyeona Bae, Rankyung Jung, Minjeong Kang, Sumin Cha, Kyu-Woan Cho, Dong-In Jung, and DoHyeon Yu
- Subjects
HEMOLYSIS & hemolysins ,INTRAVENOUS therapy ,HEMOLYTIC anemia ,MUCOUS membranes ,IDIOPATHIC thrombocytopenic purpura ,DOG bites ,THROMBOPOIETIN receptors - Abstract
A 10-year-old spayed female Maltese presented with purpura and hematemesis. Initial laboratory evaluation revealed immune-mediated thrombocytopenia, but evidence of hemolytic anemia was not identified. Three milligrams of human intravenous immunoglobulin (hIVIG) was administered for 3 hours following prednisolone and mycophenolate mofetil. A pale mucous membrane was identified, and the packed cell volume decreased by 3%. Blood film examination revealed significant spherocytosis with auto-agglutination. Blood transfusions and immunosuppression were continued for 4 days, and hIVIG was discontinued. This report describes a case of increased immune-mediated hemolysis after hIVIG administration, possibly due to new-onset immune-mediated hemolytic anemia or enhanced immunogenicity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF